AI-Supported Mobile High-Impact and Strengthening Exercise Program in Postmenopausal Women With Low Bone Density
NCT07918716, Not applicable, Active not recruiting, Istanbul University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | AI-Supported Mobile High-Impact and Strengthening Exercise Program in Postmenopausal Women With Low Bone Density | ClinicalTrials.gov |
| NCT number | NCT07918716 | ClinicalTrials.gov |
| Status | Active not recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 76 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Istanbul University | ClinicalTrials.gov |
| Conditions | Osteopenia | ClinicalTrials.gov |
| Interventions | AI-Supported Mobile Health Application, Home-Based Exercise Program | ClinicalTrials.gov |
| First posted | 2026-11-05 | ClinicalTrials.gov |
| Last updated | 2026-11-05 | ClinicalTrials.gov |
Registered outcomes 7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change From Baseline in Lumbar Spine (L1-L4) Bone Mineral Density | Baseline and 6 months | Lumbar spine (L1-L4) bone mineral density will be measured by dual-energy X-ray absorptiometry (DXA). The outcome will be expressed as the mean change in bone mineral density from baseline to 6 months, in g/cm². | ClinicalTrials.gov |
| Secondary | Change From Baseline in Femoral Neck Bone Mineral Density | Baseline and 6 months | Femoral neck bone mineral density will be measured by dual-energy X-ray absorptiometry (DXA). The outcome will be expressed as the mean change in bone mineral density from baseline to 6 months, in g/cm². | ClinicalTrials.gov |
| Secondary | Change From Baseline in Total Hip Bone Mineral Density | Baseline and 6 months | Total hip bone mineral density will be measured by dual-energy X-ray absorptiometry (DXA). The outcome will be expressed as the mean change in bone mineral density from baseline to 6 months, in g/cm². | ClinicalTrials.gov |
| Secondary | Change From Baseline in Timed Up and Go (TUG) Test | Baseline and 6 months | Functional status will be assessed with the Timed Up and Go test, which measures the time in seconds required to rise from a chair, walk 3 meters, turn, walk back, and sit down. Shorter times indicate better functional status. | ClinicalTrials.gov |
| Secondary | Change From Baseline in Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) Score | Baseline and 6 months | Quality of life will be assessed with the QUALEFFO-41 questionnaire. Total scores range from 0 to 100, with higher scores indicating worse quality of life. | ClinicalTrials.gov |
| Secondary | Exercise Adherence Rating Scale (EARS) Score | 1 month and 6 months | Self-reported exercise adherence, as an indicator of active participation in the exercise program, will be assessed with the Exercise Adherence Rating Scale at 1 month and 6 months after the start of the intervention. The adherence score ranges from 0 to 24, with higher scores indicating better adherence. | ClinicalTrials.gov |
| Secondary | Change From Baseline in Fall Risk Index Measured by Computerized Posturography | Baseline and 6 months | Fall risk will be assessed with the Tetrax Interactive Balance System, a posturographic device that calculates a fall risk index ranging from 0 to 100 based on postural sway measurements in eight standing positions. Higher scores indicate greater fall risk. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)